OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
OPKO Health (Nasdaq: OPK) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, scheduled for January 13-16, 2025, at the Westin St. Francis hotel in San Francisco.
The company's management will conduct one-on-one meetings with investors and deliver a presentation on Wednesday, January 15th at 3:00 p.m. Pacific time. Interested parties can access the live webcast and replay of the presentation through the Investors section of OPKO Health's website.
Positive
- None.
Negative
- None.
News Market Reaction – OPK
In the trading session that priced this news, OPK declined 0.68%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, Jan. 09, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 43rd Annual J.P. Morgan Healthcare Conference, being held January 13-16, 2025 at Westin St. Francis hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 15th at 3:00 p.m. Pacific time.
The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
